LETM2
gene geneOn this page
Also known as FLJ25409SLC55A2
Summary
LETM2 (leucine zipper and EF-hand containing transmembrane protein 2, HGNC:14648) is a protein-coding gene on chromosome 8p11.23, encoding LETM1 domain-containing protein LETM2, mitochondrial (Q2VYF4).
Predicted to enable transmembrane transporter activity. Predicted to be involved in mitochondrial calcium ion transmembrane transport and mitochondrion organization. Located in mitochondrion.
Source: NCBI Gene 137994 — RefSeq curated summary.
At a glance
- GWAS associations: 12
- Clinical variants (ClinVar): 72 total
- MANE Select transcript:
NM_001286819
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14648 |
| Approved symbol | LETM2 |
| Name | leucine zipper and EF-hand containing transmembrane protein 2 |
| Location | 8p11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25409, SLC55A2 |
| Ensembl gene | ENSG00000165046 |
| Ensembl biotype | protein_coding |
| OMIM | 620380 |
| Entrez | 137994 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 11 protein_coding, 3 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000297720, ENST00000379957, ENST00000518121, ENST00000518883, ENST00000519476, ENST00000523268, ENST00000523983, ENST00000524874, ENST00000526075, ENST00000526356, ENST00000527175, ENST00000527334, ENST00000527710, ENST00000528827, ENST00000530448, ENST00000889546, ENST00000948387
RefSeq mRNA: 9 — MANE Select: NM_001286819
NM_001199659, NM_001199660, NM_001286787, NM_001286819, NM_001286821, NM_001330515, NM_001363204, NM_001363205, NM_144652
CCDS: CCDS56534, CCDS6106, CCDS69466, CCDS75731, CCDS83282
Canonical transcript exons
ENST00000379957 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001527473 | 38394098 | 38394241 |
| ENSE00001806127 | 38392542 | 38392995 |
| ENSE00002122767 | 38386476 | 38386568 |
| ENSE00003526354 | 38400272 | 38400409 |
| ENSE00003526982 | 38400853 | 38401053 |
| ENSE00003528064 | 38402525 | 38402644 |
| ENSE00003536187 | 38407362 | 38407463 |
| ENSE00003542896 | 38404393 | 38404506 |
| ENSE00003589066 | 38406946 | 38407038 |
| ENSE00003661105 | 38387950 | 38388030 |
| ENSE00003901386 | 38408212 | 38409527 |
Expression profiles
Bgee: expression breadth ubiquitous, 173 present calls, max score 90.16.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.7601 / max 249.4772, expressed in 1515 samples.
FANTOM5 promoters (11 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 88490 | 4.5793 | 1280 |
| 88495 | 1.5223 | 414 |
| 88497 | 1.0469 | 312 |
| 88493 | 0.4509 | 198 |
| 88496 | 0.2946 | 112 |
| 88494 | 0.2878 | 129 |
| 88486 | 0.2632 | 95 |
| 88489 | 0.1522 | 53 |
| 88488 | 0.0929 | 39 |
| 88487 | 0.0484 | 24 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 90.16 | gold quality |
| right testis | UBERON:0004534 | 89.49 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 89.26 | gold quality |
| cerebellar cortex | UBERON:0002129 | 89.02 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 88.85 | gold quality |
| testis | UBERON:0000473 | 87.59 | gold quality |
| cerebellum | UBERON:0002037 | 86.66 | gold quality |
| secondary oocyte | CL:0000655 | 80.90 | gold quality |
| islet of Langerhans | UBERON:0000006 | 78.05 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 77.30 | gold quality |
| adenohypophysis | UBERON:0002196 | 76.01 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.94 | gold quality |
| cortical plate | UBERON:0005343 | 75.87 | gold quality |
| oocyte | CL:0000023 | 75.78 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.70 | gold quality |
| right coronary artery | UBERON:0001625 | 75.62 | gold quality |
| left uterine tube | UBERON:0001303 | 75.61 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 75.54 | gold quality |
| leukocyte | CL:0000738 | 75.41 | gold quality |
| body of pancreas | UBERON:0001150 | 75.39 | gold quality |
| omental fat pad | UBERON:0010414 | 75.24 | gold quality |
| right frontal lobe | UBERON:0002810 | 75.17 | gold quality |
| peritoneum | UBERON:0002358 | 75.15 | gold quality |
| granulocyte | CL:0000094 | 75.13 | gold quality |
| pancreas | UBERON:0001264 | 75.00 | gold quality |
| monocyte | CL:0000576 | 74.98 | gold quality |
| thoracic aorta | UBERON:0001515 | 74.77 | gold quality |
| ascending aorta | UBERON:0001496 | 74.72 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 74.39 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 74.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
46 targeting LETM2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-4648 | 99.91 | 67.00 | 710 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-4643 | 99.49 | 67.63 | 1791 |
| HSA-MIR-203A-3P | 99.49 | 70.56 | 2806 |
| HSA-MIR-6081 | 99.48 | 66.07 | 1446 |
| HSA-MIR-1324 | 99.46 | 66.57 | 1302 |
| HSA-MIR-516A-3P | 99.46 | 67.96 | 1378 |
| HSA-MIR-516B-3P | 99.46 | 67.96 | 1378 |
| HSA-MIR-7162-5P | 99.46 | 68.08 | 1368 |
| HSA-MIR-4735-5P | 99.43 | 68.49 | 1780 |
| HSA-MIR-940 | 99.37 | 66.14 | 2064 |
| HSA-MIR-6808-5P | 99.31 | 66.23 | 2150 |
| HSA-MIR-6893-5P | 99.31 | 66.25 | 2119 |
| HSA-MIR-5584-3P | 99.23 | 68.79 | 1351 |
| HSA-MIR-140-3P | 99.04 | 67.69 | 1324 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | letm2 | ENSDARG00000077515 |
| mus_musculus | Letm2 | ENSMUSG00000037363 |
| rattus_norvegicus | Letm2 | ENSRNOG00000026180 |
Paralogs (2): LETMD1 (ENSG00000050426), LETM1 (ENSG00000168924)
Protein
Protein identifiers
LETM1 domain-containing protein LETM2, mitochondrial — Q2VYF4 (reviewed: Q2VYF4)
Alternative names: LETM1 and EF-hand domain-containing protein 2, Leucine zipper-EF-hand-containing transmembrane protein 1-like
All UniProt accessions (8): A8K1M9, E5RJN4, E5RK40, Q2VYF4, E9PIC7, E9PMA4, E9PN52, H0YCZ8
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Mitochondrion inner membrane.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q2VYF4-1 | 1 | yes |
| Q2VYF4-2 | 2 | |
| Q2VYF4-3 | 3 | |
| Q2VYF4-4 | 4 |
RefSeq proteins (9): NP_001186588, NP_001186589, NP_001273716, NP_001273748, NP_001273750, NP_001317444, NP_001350133, NP_001350134, NP_653253 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR033122 | LETM1-like_RBD | Domain |
| IPR044202 | LETM1/MDM38-like | Family |
| IPR045742 | LETM2_N | Domain |
Pfam: PF07766, PF19324
UniProt features (17 total): splice variant 4, compositionally biased region 3, topological domain 2, region of interest 2, transit peptide 1, chain 1, sequence conflict 1, transmembrane region 1, domain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2VYF4-F1 | 62.77 | 0.15 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 106 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_UP, SHEPARD_BMYB_MORPHOLINO_UP, CREBP1_Q2, GOBP_MONOATOMIC_CATION_TRANSPORT, CREB_Q4, E4F1_Q6, GOCC_MITOCHONDRIAL_ENVELOPE, AACTTT_UNKNOWN, SENESE_HDAC1_TARGETS_UP, GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT, GOCC_ORGANELLE_INNER_MEMBRANE, MARSON_BOUND_BY_FOXP3_STIMULATED, YATGNWAAT_OCT_C, GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING
GO Biological Process (2): mitochondrial calcium ion transmembrane transport (GO:0006851), mitochondrion organization (GO:0007005)
GO Molecular Function (2): transmembrane transporter activity (GO:0022857), ribosome binding (GO:0043022)
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| calcium ion transmembrane transport | 1 |
| organelle organization | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| ribonucleoprotein complex binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
947 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LETM2 | GOT1L1 | Q8NHS2 | 567 |
| LETM2 | NSD3 | Q9BZ95 | 553 |
| LETM2 | RAB11FIP1 | Q6WKZ4 | 543 |
| LETM2 | BRF2 | Q9HAW0 | 526 |
| LETM2 | DDHD2 | O94830 | 522 |
| LETM2 | SIRAL2 | Q9NWS6 | 491 |
| LETM2 | PLPP5 | Q8NEB5 | 478 |
| LETM2 | MICU1 | Q9BPX6 | 462 |
| LETM2 | RHBDD3 | Q9Y3P4 | 461 |
| LETM2 | BAG4 | O95429 | 448 |
| LETM2 | TACC1 | O75410 | 448 |
| LETM2 | PLPBP | O94903 | 448 |
| LETM2 | REEP6 | Q96HR9 | 446 |
| LETM2 | DNAJC18 | Q9H819 | 427 |
| LETM2 | LSM1 | O15116 | 420 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GABARAPL1 | psi-mi:“MI:0914”(association) | 0.350 | |
| ATG16L1 | psi-mi:“MI:0914”(association) | 0.350 | |
| LETM2 | GAPDHS | psi-mi:“MI:0914”(association) | 0.350 |
| LETM1 | LETM2 | psi-mi:“MI:0914”(association) | 0.350 |
| LETM2 | EIF3CL | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (78): LETM2 (Synthetic Lethality), GAPDHS (Affinity Capture-MS), TCTEX1D2 (Affinity Capture-MS), PNMA2 (Affinity Capture-MS), LETM2 (Cross-Linking-MS (XL-MS)), LETM2 (Cross-Linking-MS (XL-MS)), LETM2 (Affinity Capture-MS), AHNAK (Affinity Capture-MS), AK4 (Affinity Capture-MS), AMOT (Affinity Capture-MS), AP2A2 (Affinity Capture-MS), APMAP (Affinity Capture-MS), ARL6IP5 (Affinity Capture-MS), ARPC4 (Affinity Capture-MS), ASAH1 (Affinity Capture-MS)
ESM2 similar proteins: A2VD95, A4UMC5, D6WIX5, E7EXT2, O13920, O95202, P70302, P84903, P91927, P91928, Q06493, Q08CK1, Q0P4W3, Q0VA06, Q0VCA3, Q13586, Q1KKT4, Q1L987, Q1LY46, Q28DA8, Q29RR5, Q2VYF4, Q3ZC62, Q498P2, Q58CP9, Q5FW14, Q5PQQ5, Q5RAS1, Q5RJT2, Q5U2Y6, Q5XIN6, Q5ZK33, Q5ZKM1, Q66JD1, Q6DI35, Q6PFM4, Q7TNU7, Q7ZU80, Q7ZYV9, Q80X82
Diamond homologs: O13920, O95202, P91927, Q06493, Q08179, Q0VA06, Q0VCA3, Q1LY46, Q28DA8, Q2VYF4, Q5PQQ5, Q5XIN6, Q5ZK33, Q7TNU7, Q9Z2I0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
72 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 61 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1840 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:38401051:G:GT | donor_gain | 1.0000 |
| 8:38401051:GAA:G | donor_gain | 1.0000 |
| 8:38401054:G:GG | donor_gain | 1.0000 |
| 8:38402519:TTTCA:T | acceptor_loss | 1.0000 |
| 8:38402520:TTCA:T | acceptor_loss | 1.0000 |
| 8:38402522:CA:C | acceptor_loss | 1.0000 |
| 8:38402523:A:AG | acceptor_gain | 1.0000 |
| 8:38402523:AG:A | acceptor_loss | 1.0000 |
| 8:38402524:G:GA | acceptor_gain | 1.0000 |
| 8:38402524:GAT:G | acceptor_gain | 1.0000 |
| 8:38402524:GATA:G | acceptor_gain | 1.0000 |
| 8:38402642:G:GT | donor_gain | 1.0000 |
| 8:38402642:GAGG:G | donor_loss | 1.0000 |
| 8:38402645:GCA:G | donor_loss | 1.0000 |
| 8:38402646:CAA:C | donor_loss | 1.0000 |
| 8:38404383:C:A | acceptor_gain | 1.0000 |
| 8:38404391:A:AG | acceptor_gain | 1.0000 |
| 8:38404391:AGT:A | acceptor_gain | 1.0000 |
| 8:38404391:AGTG:A | acceptor_gain | 1.0000 |
| 8:38404392:G:GA | acceptor_gain | 1.0000 |
| 8:38404392:GT:G | acceptor_gain | 1.0000 |
| 8:38404392:GTG:G | acceptor_gain | 1.0000 |
| 8:38404392:GTGG:G | acceptor_gain | 1.0000 |
| 8:38404392:GTGGC:G | acceptor_gain | 1.0000 |
| 8:38404502:GGGAG:G | donor_gain | 1.0000 |
| 8:38404503:GGAG:G | donor_gain | 1.0000 |
| 8:38404503:GGAGG:G | donor_gain | 1.0000 |
| 8:38404504:GAG:G | donor_gain | 1.0000 |
| 8:38404504:GAGG:G | donor_gain | 1.0000 |
| 8:38404505:AGG:A | donor_loss | 1.0000 |
AlphaMissense
3191 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:38404393:T:A | W369R | 0.994 |
| 8:38404393:T:C | W369R | 0.994 |
| 8:38404395:G:C | W369C | 0.990 |
| 8:38404395:G:T | W369C | 0.990 |
| 8:38402568:T:C | L343P | 0.989 |
| 8:38401016:T:C | L316P | 0.988 |
| 8:38402637:T:C | L366P | 0.988 |
| 8:38400950:T:C | L294P | 0.986 |
| 8:38402625:T:C | L362P | 0.986 |
| 8:38401048:G:C | D327H | 0.985 |
| 8:38400324:T:C | L233P | 0.984 |
| 8:38402595:T:C | M352T | 0.980 |
| 8:38404403:T:C | L372P | 0.979 |
| 8:38404421:T:A | V378D | 0.978 |
| 8:38400320:T:C | F232L | 0.977 |
| 8:38400322:T:A | F232L | 0.977 |
| 8:38400322:T:G | F232L | 0.977 |
| 8:38394099:T:C | L168P | 0.976 |
| 8:38401004:T:C | L312P | 0.976 |
| 8:38401049:A:T | D327V | 0.976 |
| 8:38394221:T:C | F209L | 0.974 |
| 8:38394223:T:A | F209L | 0.974 |
| 8:38394223:T:G | F209L | 0.974 |
| 8:38402589:G:C | R350P | 0.974 |
| 8:38404436:T:C | L383S | 0.973 |
| 8:38400959:T:C | L297P | 0.972 |
| 8:38402576:G:C | A346P | 0.972 |
| 8:38401048:G:T | D327Y | 0.971 |
| 8:38401049:A:C | D327A | 0.971 |
| 8:38401028:T:C | L320P | 0.970 |
dbSNP variants (sampled 300 via entrez): RS1000202792 (8:38392005 G>T), RS1000365460 (8:38402697 T>C), RS1000448269 (8:38387358 G>C), RS1000497460 (8:38397607 T>C,G), RS1000592143 (8:38408799 G>A,T), RS1000633807 (8:38402167 G>A,C), RS1000670706 (8:38408714 C>G,T), RS1000871328 (8:38388752 T>G), RS1000891603 (8:38383604 T>A), RS1000944339 (8:38388434 C>G), RS1001117987 (8:38391277 T>C), RS1001143624 (8:38380917 A>G), RS1001224889 (8:38405059 G>C), RS1001277831 (8:38382209 G>A), RS1001305087 (8:38404841 G>A,C)
Disease associations
OMIM: gene MIM:620380 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
12 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003469_12 | Response to cognitive-behavioural therapy in anxiety disorder | 4.000000e-06 |
| GCST004521_242 | Autism spectrum disorder or schizophrenia | 4.000000e-09 |
| GCST004946_16 | Schizophrenia | 1.000000e-11 |
| GCST006803_65 | Schizophrenia | 6.000000e-10 |
| GCST007201_408 | Schizophrenia | 1.000000e-06 |
| GCST007201_97 | Schizophrenia | 1.000000e-12 |
| GCST007269_277 | Pulse pressure | 2.000000e-11 |
| GCST008103_171 | Bipolar disorder | 7.000000e-06 |
| GCST009600_31 | Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) | 2.000000e-09 |
| GCST90000025_329 | Appendicular lean mass | 1.000000e-21 |
| GCST90002387_394 | Immature fraction of reticulocytes | 8.000000e-15 |
| GCST90002388_241 | Lymphocyte count | 8.000000e-15 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007820 | cognitive behavioural therapy |
| EFO:0005763 | pulse pressure measurement |
| EFO:0004980 | appendicular lean mass |
| EFO:0004587 | lymphocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC55 Mitochondrial cation/proton exchangers
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| (+)-JQ1 compound | decreases expression, increases expression | 2 |
| Benzo(a)pyrene | increases expression | 2 |
| Smoke | decreases expression, increases expression | 2 |
| Cyclosporine | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, increases methylation | 1 |
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| pentanal | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| monomethylarsonous acid | increases expression | 1 |
| abrine | increases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Leflunomide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Quercetin | increases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Theophylline | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Vanadates | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4G1 | HCT116-LETM2-KO-c11 | Cancer cell line | Male |
| CVCL_D4G2 | HCT116-LETM2-KO-c2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): anorexia nervosa, obsessive-compulsive disorder